Market Intelligence * Industry Reports * PMR Publications

Almost 2,300 clinical trials to be conducted in Central Europe in 2014 - May 2012

Tue, 22 May 2012 00:00:00 +0200

The Central European (CE)1 region has, in recent years, been extensively affected by changes in global trends pertaining to clinical trials, mainly because of the regulatory and economic developments in the countries involved. Rising costs have forced global concerns to increase their total spending on research and development. As a consequence, global ...

Jak ustawa refundacyjna wpłynie na rozwój polskiego rynku farmaceutycznego? - kwiecień 2012

Fri, 20 Apr 2012 00:00:00 +0200

Ustawa refundacyjna, która weszła w życie od 1 stycznia 2012 r. wpłynie negatywnie na dynamikę wzrostu zarówno leków innowacyjnych jak i generycznych w Polsce, wynika z naszego najnowszego raportu pt. „Rynek leków generycznych i innowacyjnych w Polsce 2012. Prognozy rozwoju na lata 2012-2014”. Ustawa o refundacji z 12 maja 2011 r., ...

How will the Reimbursement Act impact the Polish pharma market? - April 2012

Fri, 20 Apr 2012 00:00:00 +0200

The Reimbursement Act, which came into force on 1 January 2012, will have an adverse effect on the growth recorded by both original and generic drugs in Poland, according to our latest report, entitled “Generic and innovative drugs market in Poland 2012. Development forecasts for 2012-2014.” The Reimbursement Act of 12 May 2011, whose provisions ...

Legislative changes to hamper innovative drugs market in Central Europe between 2012 and 2014 - April 2012

Thu, 12 Apr 2012 00:00:00 +0200

Due to legislative changes implemented during 2011 in most of the Central European (CE) countries, the innovative drug market in the region will decline in 2012 by 1%, to €6.1bn at manufacturer prices, according to information contained in our latest report entitled “Generic and innovative drugs market in Central Europe 2012. Comparative ...

Większość szpitali niepublicznych w Polsce nastawiona na publiczne finansowanie - luty 2012

Fri, 24 Feb 2012 00:00:00 +0100

Zdecydowana większość szpitali niepublicznych w Polsce oferuje świadczenia w ramach kontraktów z NFZ. W Polsce wciąż niewielu pacjentów stać na opłacanie drogich świadczeń szpitalnych z własnej kieszeni, stąd podpisanie kontraktu z NFZ jest dla placówki niepublicznej gwarantem pewnego pułapu przychodów i pewnej liczby pacjentów. Dlatego też nawet szpitale prywatne, które początkowo ...

Most non-public hospitals in Poland oriented towards public funding - February 2012

Fri, 24 Feb 2012 00:00:00 +0100

The vast majority of non-public hospitals in Poland provide services under contracts with the National Health Fund (NFZ). The number of Poles who can afford to pay for costly hospital procedures out of their own pockets remains small, whereas NFZ contracts guarantee a certain level of revenues and patient numbers. That is why even those private hospitals ...

The clinical trials market in CIS countries continues to grow - February 2012

Mon, 06 Feb 2012 00:00:00 +0100

Clinical trials in the CIS countries have been developing in a positive fashion (with the exception of Russia, whose development slowed for a while as a result of significant changes in regulations). The expected average growth in value will reach 14% and approximately 13% by volume in the years 2012-2014, according to the newest PMR Publications report “Clinical ...

Boom expected on medical equipment market in Poland in 2013 - December 2011

Fri, 16 Dec 2011 00:00:00 +0100

In 2010 the overall Polish medical equipment market grew by 5% year on year. The increase primarily reflected imports, which grew by 6%, to PLN 3.9bn (€1.0bn). According to the most recent PMR report “Medical devices market in Poland 2012. Development forecast for 2012-2014”, the market experienced a greater rate of growth in 2011. ...

Rynek sprzętu medycznego w Polsce przyspieszy w 2013 r.- grudzień 2011

Fri, 16 Dec 2011 00:00:00 +0100

Według najnowszego raportu PMR Publications „Rynek sprzętu medycznego w Polsce 2012. Prognozy rozwoju na lata 2012-2014”, w 2010 r. wartość rynku sprzętu medycznego wzrosła o 5% w stosunku do poprzedniego roku. Wzrost ten napędzany był przede wszystkim przez import, którego dynamika wyniosła 6%, do wartości 3,9mld zł. W 2011 r. rynek ...

Growth forecasts for the Polish market of dietary supplements - December 2011

Wed, 07 Dec 2011 00:00:00 +0100

In 2011-2013, the market of dietary supplements in Poland will develop at a rate of 9-15% annually, according to the latest report published by PMR entitled „Dietary supplements market in Poland 2011. Development forecasts for 2011-2013”. Although the market growth rate is lower than in the preceding year, it should be noted that it still ...